Elicio Therapeutics, Inc entered into a Subscription Agreement and completed a private placement of 1,213,000 shares par value $0.01 per share, at a purchase price per Share of $5.81 for gross proceeds of $1,213,000 on December 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.05 USD | -4.28% | -9.14% | -3.48% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.48% | 77.88M | |
+44.80% | 56.69B | |
-3.21% | 41B | |
+39.64% | 38.11B | |
-11.22% | 26.89B | |
+8.47% | 25.59B | |
-23.09% | 18.59B | |
-1.44% | 12.39B | |
+25.50% | 11.99B | |
+22.14% | 11.88B |
- Stock Market
- Equities
- ELTX Stock
- News Elicio Therapeutics, Inc.
- Elicio Therapeutics, Inc. announced that it has received $7.04753 million in funding